Kaluski E, Gerula C, Randhawa P, Klapholz M. Funneling: Enhancing Results of
Small Vessels Stenting. Cardiovascular Revascularization Medicine 2009;10(4):255-8.
62. Kaluski E, Moussa I, Heuser RR, Kern M, Weitz G, Klapholz M, Gerula C, Automated
Contrast Injectors for Angiography: Devices, Methodology and Safety. Catheterization
Cardiovascular Interventions; September 1, 2009; 74(3):459-464.
63. Torre-Amione G, Milo-Cotter O, Kaluski E, Perchenet L, Kobrin K, Frey A, Davison
Weatherley B, Cotter G. Early Worsening Heart Failure in Patients Admitted for Acute
Heart Failure: Time Course, Hemodynamic Predictors and Outcome. Journal of Cardiac
Failure; October 2009; 15(8):639-644.
64. Kfir E, Goldstein M, Rafaelov R, Yerushalmi I, Kfir V, Mazor Z, Kaluski E. Minimally
Invasive Antral Membrane Balloon Elevation- Results of Multi-Center Registry. Clinical
Implant Dentistry and Related Research. October 2009; 11 Supplement 1; e83-91
65. Weatherley BD, Milo-Cotter O, Felker MG, Uriel N, Kaluski E, Vered Z, O’Connor
CM, Adams KF, CotterG. Early worsening heart failure in patients admitted with
acute heart failure- a new outcome measure associated with long term prognosis.
Fundamental and Clinical Pharmacology; October 2009; 23(5): 633-639.
66. Milo-Cotter O, Felker M, Uriel N, Kaluski E, Edwards C, Rund MM, Weatherly BD,
Cotter G. Patterns of Leukocyte Counts on Admissions for Acute Heart Failure –
Presentation and Outcome - Results from a Community Based Registry. International
Journal of Cardiology; November 20, 2009.
67. Kaluski E, Maher J, Gerula C, Tsai S, Randhawa P, Saric M, Oghlakian G, Alfano D,
Palmaro J, Haider B, Klapholz M. Optimizing Primary PCI Beyond Door to
Intervention Time - Are We There Yet? Cardiovascular Revascularization Medicine
2010;11(2):84-90.
68. Solanki P, Gerula C, Saric M, Randhawa P, Benz M, Maher J, Haider B, Klapholz,
Palmaro J, Alfano D, Kaluski E. Right Coronary Artery Anatomical Variants: Where
and How? Journal of Invasive Cardiology. March 2010; 22(3):103–106.
69. Rusovici A, Santosh V, Klapholz M, Saeed Q, Kaluski E. Cocaine Induced Coronary
Thrombosis: What is The Optimal Treatment Strategy. Cardiovascular Revascularization Medicine 2011 Mar-Apr;12(2):133.e1-6. Epub 2010 Oct 20.
Schmidt R, Kasper M, Klapholz M, Kaluski E. Intra-aortic Balloon Counterpulsation
Prior to Noncardiac Surgery: A Forgotten Remedy? Journal of
Invasive Cardiology. 2011 Feb;23(2):E26-30.
Grube E, Hauptmann KE, Műller R, Uriel N, Kaluski E. Coronary Stenting with
MGuard: Extended Follow-up of First Human Trial. Cardiovascular Revascularization
Medicine. 2011 May-Jun;12(3):138-46. Epub 2010 Oct 20
Sanchez-Ross M, Oghlakian G, Maher J, Patel B, Mazza V, Hom D, Dhruva V,
Langley D, Palmaro J, Ahmed S, Kaluski E, Klapholz M. The STAT-MI (ST-Segment
Analysis Using Wireless Technology in Acute Myocardial Infarction) Trial Improves
Outcomes. JACC Cardiovasc Interv. 2011 Feb;4(2):222-7. PubMed PMID: 21349462.
Kfir E, Kfir V, Mazor Z, Kaluski E, Goldstein M. Minimally invasive antral membrane balloon elevation for single tooth placement. Quintessence International; 2011; Sep (42-8): Sep;42(8):645-50.
Kfir E, Kfir V, Mazor Z, Goldstein M, Kaluski E. Minimally Invasive Sub-nasal Elevation and Antral Membrane Balloon Elevation along with Bone Augmentation and Implants Placement Accepted for publication in the Journal of Oral Implantology 2011 Jun 13. [Epub ahead of print]
Milo-Cotter, Kaluski E, Edwards C, Rund MM, Weatherly BD, Cotter G. Neurohormonal activation in acute heart failure: results from VERITAS Cardiology. 2011;119(2):96-105. Epub 2011 Sep 8.
Clinical efficacy and safety of intracoronary nitroprusside for assessing fractional flow reserve. Rudzinski W, Waller A, MD, Rusovici A, Dehnee A, Nasur A, Benz M, Sanchez S, CVT, Klapholz M, Kaluski E. Accepted for publication Catheterization and Cardiovascular Interventions.
Kfir E, Goldestein M, Abramovitz I, Mazor Z, Kfir V, Kaluski E. The effects of
sinus membrane pathology on bone augmentation and procedural outcome using
minimal invasive antral membrane balloon elevation. J Oral Implantol. 2012 Mar 5.
[Epub ahead of print] PubMed PMID: 22390820.
22. Books, Monographs and Chapters
Fink MP, Abraham E, Vincent JL, Kochanek P. Textbook of Critical Care 5th Edition, Chapter on “Pulmonary Edema” Elsevier Inc. Chapter 90 “Pulmonary Edema” (pages 719-731)
O’Connor C, Stough WG, Adams KF, Gheorghiade M, Managing Acute Decompensated Heart Failure (2005) Taylor & Francis Chapter on “Cardiogenic shock” (pages 221-240)
Vincent J, Abraham E, Moore FA, Kochanek PM, Fink MP, Textbook of Critical Care 6th Edition, Chapter 73 “Pulmonary Edema” (pages 516-530) Elsevier – Saunders Inc. 2011
23. Abstracts
1. Kaluski E, Miller HI. Intracoronary Stents-The Tel-Aviv Experience. Israel
Journal of Medical Sciences 1990; 26:225.
2. Kaluski E, Popma JJ, Satler LF, et al. Non-Q wave myocardial infarction after
Rotational atherectomy: Predictors and clinical outcome [Abstr]. Presented at the
Israeli Heart Society Meeting April 1997. Published in the Israeli Journal of Medical
Sciences April 1997.
Kaluski E, Satler LF, Leon MB, Popma JJ. Coronary angioplasty of restenotic lesions: Immediate and long term results of a multi-device registry. Presented at the
Israeli Heart Society Meeting April 1997. Published in the Israeli Journal of Medical
Sciences April 1997.
Kaluski E, Satler LF, Leon MB, Popma JJ. Rotational atherectomy assisted angioplasty: procedural and long term outcome in restenotic versus de-novo lesions. Accepted for presentation at the Israeli Heart Society Meeting April 1997.
Kaluski E, Popma JJ, Bucher T, Merritt A, Leon MB. Multi-device coronary angioplasty in patients with chronic renal failure: immediate and long term results . Accepted for presentation at the Israeli Heart Society meeting April 1997.
Zysman I., Hendler A., Reicher M., Peleg E., Kaluski E., Krakover et-al. Instent restenosis in single vessel disease: Clinical Angiographic and technical variables. Journal of Interventional Cardiology Vol. 9, Supplement C 1997, 73C.
7. Cotter G., Metzkur E., Kaluski E., et-al. Administration of Intravenous high dose
isosorbide dinitrate boluses better than furosemide in controlling pulmonary edema
and preventing mechanical ventilation. Presented in the 19th congress of the European
Society of Cardiology August 1997, Stockholm , Sweden. Printed in the European
Heart Journal, August Abstract Supplement 1997.
8. Cotter G., Metzkor-Cotter E., Kaluski E., et-al. Losartan, captopril and furosemide in
the prevention of nitrate tolerance and control of unstable angina. [Abstract] Presented
in American Heart Association Meeting Orlando October 1997. Printed in Circulation,
October 1997.
9. Cotter G., Metzkur - Cotter E., Kaluski E., et-al. Acute atrial fibrillation: high dose IV
amiodarone facilitates conversion to normal sinus rhythm. When is it necessary?
Accepted for presentation in the ACC February 1998. Printed in Journal of the
American College of Cardiology Abstract Supplement, February 1998.
10. Zimmerman E., Krakover R., Peleg E., Cotter G, Kaluski E. Post- PTCA flushing of
femoral arterial sheaths by high pressure heparinized solution- is this practice really
warranted? [In-print] Presented in the Israeli Heart Society Meeting April 1998. The
Journal of Israel Heart Society; April 1998; p54.
11. Kaluski E., Hendler A., Zysman I, Cotter G., Petrov O., Krakover R. Unmonitored
very low dose heparin in coronary angioplasty. Presented in the Israeli Heart Society
Meeting April 1998. The Journal of Israel Heart Society; April 1998; p17.
12. Lytkin J., Avidov A., Maleikhov I., Meshulam R., Cotter G., Kaluski E. Persistent
echo-contrast in the inferior vena cava in acute myocardial infarction- a marker of
ventricular dysfunction and low cardiac output state. [In-print] Presented in the Israeli
Heart Society Meeting April 1998. The Journal of Israel Heart Society; April 1998; p-
41.
13. Kaluski E., Zimmerman E., Cotter G., Hendler A., Krakover R. Shotened cardiac
monitoring post- PTCA. [In-print] Presented in the Israeli Heart Society
Meeting April 1998. The Journal of Israel Heart Society; April 1998.
14. E. Kaluski., Cotter G., Peleg E., Krakover R. Periprocedural routines of coronary
angioplasty- extreme diversity with unrevealed consequences. In-print [Abstract] ]
Presented in the Israeli Heart Society Meeting April 1998. The Journal of Israel Heart
Society; April 1998; p17.
15. Cotter G., Metzkor-Cotter E., Kaluski E., et-al. Losartan, captopril and furosemide in
the prevention of nitrate tolerance and control of unstable angina. [Abstract] Presented
in the Israeli Heart Society Meeting April 1998. The Journal of Israel Heart Society
April 1998; p13.
16. Hendler A, Vered Z, Zisman I, Peleg E, Reicher, M, Kaluski E, Krakover R Stenting
following rotational atherectomy in native large, calcified coronary arteries-is this a
panacea. Presented in the Israeli Heart Society Meeting April 1998. The Journal of Israel
Heart Society April 1998; p24.
17. E. Kaluski, O. Petrov, G. Cotter, A. Blatt, V. Nahman, R. Krakover.
Adjunctive pharmacotherapy for PTCA in Israel: current trends and future questions.
International Meeting of Intensive Cardiac Care Jerusalem June 1998; p36.
18. E. Kaluski, O. Petrov, R. Gur, V. Gilad, I. Shemer, B. Cagan, R. Krakover, G Gilad.
Polyamines in acute coronary syndromes: where is it going ? [Abstract] International
Meeting of Intensive Cardiac Care Jerusalem June 1998; p27.
19. Zimmerman E., Salah A., Krakover R., Avidov A., Cotter G., Kaluski E. Post-PTCA
flushing of femoral sheaths by high pressure heparinized solution. Is this practice
really warranted? [Abstract] Presented in the 20th congress of the European Society of
Cardiology, Vienna. European Heart Journal; August 1998; Vol. 19 Abstract
Supplement; p1276 .
20. Kaluski E., Petrov O., Hendler A, Zimmerman E, Zysman I, Cotter G, Rahamim M,
Peleg E, Krakover R. Unmonitored very low dose heparin in coronary angioplasty.
Presented in the 20th congress of the European society of cardiology, Vienna. European
Heart Journal; August 1998 Vol. 19 Abstract Supplement; p3075, p561.
21. Cotter G., Metzkor-Cotter E., Kaluski E., Litinsky I., Blatt A., et al. Losartan, captopril
and furosemide in prevention nitrate tolerance and control of unstable angina pectoris.
Presented in the 20th congress of the European society of cardiology, Vienna. European
Heart Journal August 1998 Vol. 19 Abstract Supplement; p2700 and p476.
22. Cotter G., Blatt A., Cotter E., Kaluski E., Peleg E., Koren M., Zaidenstein R., Vered Z.,
Golik A. Spontaneous conversion of acute paroxysmal atrial fibrillation (PAF) occurs
commonly and can be predicted by clinical and echocardiographic parameters. Presented
in the AHA meeting, Dallas, November 1998, and published in the Abstract supplement
of the Circulation 1998;98(17) Supplement; I-103 #521.
23. Metzkor Cotter E, Cotter G, Krakover R, Buldor I, Ben-Yakov M, Kaluski E,
Zaidenstein R, Golik A. Serological markers of infectious agents are not independent
predictors of coronary heart disease. Presented in the Congress of American Society
of Microbiology 1998.
24. Kaluski E, Milovanov O, Cotter G, Nahman V, Gilad G, Gilad V, Vered Z. Spermine in
acute myocardial infarction: an early marker of myocardial necrosis and a better
predictor of infarction size. Presented in the meeting of Israel Heart Society April 1999.
25. Metzkor Cotter E, Cotter G, Krakover R, Buldor I, Ben-Yakov M, Kaluski E, Zaidenstein
R, Golik A. Serological markers of infectious agents are not independent predictors of
coronary heart disease. Presented in the meeting of Israel Heart Society April 1999.
26. Cotter G, Kaluski E, Zaidenstein R, Metzkor E, Blatt A, Peleg E, Koren M, Vered Z,
Golik A. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm:
The effects of no treatment and high dose amiodarone. Presented in the meeting of Israel
Heart Society April 1999.
27. Gurevich Y, Kaluski E, Hendler A, Zysman I, Peleg E, et al. Coronary stent implantation
without balloon predilatation in conjunction with low dose heparin [Abstract] A cost-
effective approach Presented in the meeting of Israel Heart Society [Abstract] April
1999.
28. Kaluski E, Krakover R, Cotter G, Hendler A, Zyssman I, Milovanov O, Blatt A, Leitman
M, Zimmerman M, Nahman V, Goldstein E, Vered Z. Minimal Heparin dose in PTCA- Is
heparin really warranted? - Accepted for presentation for 3rd International Meeting on
Interventional Cardiology Frontiers in Interventional Cardiology Jerusalem June 1999.
Kaluski E, Cotter G, Vered Z, Zimmerman E, Krakover R. PTCA in Israel - Current
Trends. Accepted for presentation for the 3rd International Meeting on Interventional
Cardiology: Frontiers in Interventional Cardiology, Jerusalem, June 1999. International
Journal of Cardiovascular Interventions Vol 2, Supplement 2; June 1999; p27.
30. Kaluski E, Krakover R, Cotter G, Hendler A, Zyssman I, Milovanov O, Blatt A, Leitman
M, Zimmerman M, Nahman V, Goldstein E, Vered Z. Minimal Heparin dose in PTCA- Is
heparin really warranted? [Abstract]- Accepted for presentation for the 3rd International
Meeting on Interventional Cardiology: Frontiers in Interventional Cardiology, Jerusalem,
July 1999. International Journal of Cardiovascular Interventions Vol 2, Supplement 2;
June 1999; p33.
31. Gurevich Y, Kaluski E, Hendler A, Zysman I, Peleg E, Reicher M, Vered Z, Krakover R.
Coronary stent implantation without balloon predilatation in conjunction with low dose
heparin-a cost-effective approach. [Abstract] - Accepted for presentation for the 3rd
International Meeting on Interventional Cardiology: Frontiers in Interventional
Cardiology, Jerusalem, July 1999, Published in the abstract supplement to the
International Journal of Cardiovascular Interventions, Vol 2, Supplement 2, June 1999,
p41.
32. Cotter G, Kaluski E, Blatt A, Zaidenstein R, Salah A, Milovanov O, Metzger M, Vered
Z, Golik A. L-Name is effective in the treatment of cardiogenic shock. [Abstract] -
Accepted for presentation for the 3rd International Meeting on Interventional Cardiology:
Frontiers in Interventional Cardiology, Jerusalem, June 1999, International Journal of
Cardiovascular Interventions Vol 2, Supplement 2, June 1999, p53.
Cotter G, Kaluski E, Milovanov O, Krakover R, Salah A, et al Asymptomatic ST-
Elevation after thrombolytic therapy- early invasive versus conservative therapy and its
effect on left ventricular function. Accepted for presentation for the 3rd International
Meeting on Interventional Cardiology: Frontiers in Interventional Cardiology, Jerusalem,
July 1999. International Journal of Cardiovascular Interventions Vol 2, Supplement 2,
June 1999; p48.
34. Kaluski E, Krakover R, Cotter G, Hendler A, Zyssman I, Milovanov O, Blatt A, Leitman
M, Zimmerman M, Nahman V, Goldstein E, Vered Z. Minimal Heparin dose in PTCA-
Is heparin really warranted? [Abstract] Accepted for presentation European Society of
Cardiology Meeting August 1999- Barcelona, Published in the European Heart Journal,
Vol 20 Abstract Supplement, August-September 1999; p530 (#2805).
35. Cotter G, Blatt A, Kaluski E, Metzkor-Cotter E, Koren M, Zaidenstein R, Vered Z, Golik
A. Recent onset paroxysmal atrial fibrillation-spontaneous conversion and the role of
high dose intravenous amiodarone. [Abstract] Accepted for presentation European
Society of Cardiology Meeting August 1999, Barcelona, Published in the European Heart
Journal, Vol 20, Abstract Supplement, August-September 1999; p 223 (#1239).
36. Cotter G, Kaluski E, Blatt A, Zaidenstein R, Salah A, Milovanov O, Metzger M, Vered Z,
Golik A. L-Name is effective in the treatment of cardiogenic shock. Accepted for
presentation European Society of Cardiology Meeting August 1999, Barcelona, Published
in the European Heart Journal, Vol 20, Abstract Supplement, August 1999; p92 (#612).
37. Cotter G., Kaluski E, Blatt A, Zaidenstein R, Salah A, et al. L-NAME is effective in the
treatment of cardiogenic shock. European Heart Journal, Vol 20, Abstract Supplement
August-September 1999; p92.
38. Cotter G., Blatt A., Kaluski E, Metzkor-Cotter E, Koren M, et al. Recent onset
paroxysmal atrial fibrillation: spontaneous conversion and the role of high dose
amiodarone. European Heart Journal, Vol 20, Abstract Supplement August-September
1999; p223.
39. Kaluski E, Krakover R, Cotter G, Hendler A, Zyssman I, et al. Minimal heparinization in
PTCA: is heparin really warranted? European Heart Journal, Vol 20, Abstract
Supplement August-September 1999; p530.
40. Cotter G, Kaluski E, Blatt A, Zaidenstein R, Milovanov O, Vered Z, Golik A. L-NMMA
(a Nitric Oxide Synthase Inhibitor) is Effective in the Treatment of Cardiogenic Shock.
Circulation, 100(18); 1999:I-371 [Abstract 1945] Oral presentation at the 1999 AHA
Scientific Meeting, Atlanta, Georgia.
41. Metzkor Cotter E, Cotter G, Krakover R, Boldur I, Ben-Yakov M, Kaluski E, et al. Are
infectious agents truly independent risk factors for coronary atherosclerotic disease?
AHA Scientific Session New Orleans, 2000, Circulation; Vol 102; 18; Supplement 2, II-53
(#246).
Cotter G, Kaluski E, Blatt A, Milovanov O, Moshkovitz Y, et al L-NMMA in
Cardiogenic Shock: Effective treatment inducing peripheral vasoconstriction leading to
improved myocardial contractility and normalization of vascular tone. AHA Scientific
Session New Orleans, 2000, Circulation; Vol 102; 18; Supplement 2, II-615 (#2981).
43. Kaluski E, Khiger I, Cotter G, Leitman M, Zimmerman E, Krakover R. Interventional
cardiology in Israel: trends and plans towards the new millennium. Presented in the
International Forum: Cardiology and Cardiac Surgery into the Next Millennium. (Tel-
Aviv, April 2000) Journal of Israel Heart Society Supplement April 2000: 86 [Abstract].
44. Kaluski E, Peer A, Weinman E, Vered Z, Cotter G, Krakover R, Zimmerman E, Khiger I,
Leitman M, Bass A. Carotid stenting in Assaf harofeh-Where is it going? Presented in the
International Forum: Cardiology and Cardiac Surgery into the next millennium. (Tel-Aviv,
April 2000) Journal of Israel Heart Society Supplement April 2000:85.
45. Zyssman I, Ishvi L, Blat A, Peleg E, Gurevitch Y, Reicher M, hendler A, Kaluski E,
Vered Z, Krakover R. Efficacy and safety of abbreviated protocol of eptifibatide versus
standard Protocol of abciximab in PCI. Presented in the International Forum: Cardiology
and Cardiac Surgery into the next millennium. (Tel-Aviv, April 2000) Journal of Israel
Heart Society Supplement April 2000:91.
46. Avidov A, Gottlieb S, Kaluski E, Hod H, Vered Z, Behar S. The incidence and outcome
of patients with new intraventricular conduction disturbances complicating acute
myocardial infarction. Presented in the International Forum: Cardiology and Cardiac
Surgery into the next millenium. (Tel-Aviv, April 2000) Journal of Israel Heart Society
Supplement April 2000:1.
47. Shemesh E, Rudnick A, Kaluski E, Milovanov O, Salah A et al. Noncompliance and
adverse outcome in survivors of myocardial infarction: a dysfunctional stress response?
Presented in the International Forum: Cardiology and Cardiac Surgery Into the next
millennium. (Tel-Aviv, April 2000) Journal of Israel Heart Society Supplement April
2000:14.
48. Sharon A, Shpirer I, Kaluski E, Moshkovitz Y, Milovanov O, et al. High dose intravenous
isosorbide dinitrate is safer and better than Bi-PAP ventilation combined with
conventional treatment for severe pulmonary edema. Presented in the International
Forum: Cardiology and Cardiac Surgery Into the next millennium. (Tel-Aviv, April
2000) Journal of Israel Heart Society Supplement April 2000:16.
Cotter G, Kaluski E, Blatt A, Milovanov O, Moshkovitz Y, et al. L-NMMA (a nitric
oxide synthase inhibitor), is effective in the treatment of cardiogenic shock. Presented in
the International Forum: Cardiology and Cardiac Surgery Into the next millennium. (Tel-
Aviv, April 2000) Journal of Israel Heart Society Supplement April 2000:16.
Shemesh E, Rudnick A, Kaluski E, Milovanov O, Salah A et al. Noncompliance and
adverse outcome in survivors of myocardial infarction: a dysfunctional stress response?
XXII Congress European Society of Cardiology, Amsterdam, August 2000. [Abstract].
European Heart Journal; Abstract Supplement; 21:1203.
Metzkor Cotter E, Cotter G, Krakover R, Buldor I, Ben-Yakov M, Lazarovich T, Chen-
Levy Z, Fytlovitz S, Kaluski E, Zaidenstein R, Vered Z, Golik A. Are infectious agents
truly independent risk factors for coronary atherosclerotic heart disease? XXII Congress
European Society of Cardiology, Amsterdam, August 2000. [Abstract]. European Heart
Journal; Abstract Supplement; 21:161.
Cotter G, Kioski W, Kaluski E, Kobrin A, Marmor A, et al. Tezosentan reduces
peripheral resistance and increases myocardial contractility despite reducing LV filling
(wedge) pressure in patients with congestive heart failure. XXII Congress European
Society of Cardiology, Amsterdam, August 2000. [Abstract]. European Heart Journal;
Abstract Supplement; 21:297-1649.
53. Blatt A, Robinson D, Nevo Z, Evron G, Cotter G, Siman-Tov Y, Bar Y, Kaluski E,
Krakover R, Vered Z. Successful satellite cell grafting in rabbits following myocardial
infarction. XXII Congress European Society of Cardiology, Amsterdam, August 2000
European Heart Journal Abstract Supplement; 21: 60.
54. Avidov A, Gottlieb S, Kaluski E, et al Incidence and outcome of patients with new
conduction disturbance complicating acute myocardial infarction. XXII Congress
European Society of Cardiology, Amsterdam, August 2000 European Heart Journal
Abstract Supplement; 21: #2968.
55. Cotter G, Kaluski E, Milovanov O, Blatt A, Salah A, Krakover R, Vered Z. LINCS: L-
NMMA in cardiogenic shock: preliminary results from a prospective randomized study.
Presented in the ACC Meeting, Orlando, 2001. Published in Journal of American College
of Cardiology 2001;37-2; Supplement A:153A.
56. Blatt A, Robinson D, Nevo Z, Cotter G, Kaluski E, Vered Z. Successful satellite cells
grafting following myocardial infarction in rabbits. Presented in the ACC Meeting,
Orlando, 2001. Published in Journal of American College of Cardiology 2001;37-2
Supplement A:183A.
57. Milovanov O, Cotter G, Kaluski E, Hendler A, Blatt A et al. Early (<24 hours)
catheterizationin patients with asymptomatic persistent ST elevation after thrombolytic
treatment for acute MI: costly complicated procedure not improving 6 months clinical
outcome end echocardiographic left ventricular function. Presented in the IHS meeting
Jerusalem, April 2001. Journal of the Israel Heart Society, 2001; Supplement:8.
58. Blatt A, Robinson D, Nevo Z, Efrati S, Simantov Y, Bar I Cotter G, Kaluski E et al.
Improved regional left ventricular function after successful satellite grafting in rabbits with
myocardial infarction. Presented in the IHS meeting Jerusalem, April 2001. Journal of the
Israel Heart Society, 2001; Supplement:16.
59. Cotter G, Moshkowitz Y, Kaluski E, Krakover R, Nobikov Y, et al. The role of cardiac
power index and systemic vascular resistance in the pathophysiology, diagnosis and
treatment titration of patients with CHF due to systolic dysfunction, pulmonary edema and
cardiogenic shock. Presented in the IHS meeting Jerusalem, April 2001. Journal of the
Israel Heart Society, 2001; Supplement:20.
60. Moshkowitz Y, Tzuglin A, Cotter G, Kaluski E, Goor D, et al. Reliability of non-invasive
cardiac output measurements by whole body electrical bioimpedance: comparison to
thermodilution in diverse clinical settings. Presented in the IHS meeting Jerusalem, April
2001. Journal of the Israel Heart Society, 2001; Supplement:20.
61. Cotter G, Kaluski E, Milovanov O, Salah A, Krakover R, et al. LINCS: L-NMMA in
cardiogenic shock: preliminary results from a prospective randomized trial. Presented in
the IHS meeting Jerusalem, April 2001. Journal of the Israel Heart Society, 2001;
Supplement:52.
62. Cotter G, Kiowski W, Kaluski E, Kobrin I, Marmor A, et al. Are all vasodilator
treatments for CHF equal? A comparison of the hemodynamic effects of Tezosantan to
nitrates and natriuretic peptide. Presented in the IHS meeting Jerusalem, April 2001.
Journal of the Israel Heart Society, 2001; Supplement:61
63. Cotter G, Tzoglin A, Moshkovitz Y, Kaluski E, Vered Z, Goor DA, Whole body electrical
bio-impedance for non-invasive determination of cardiac output: A thermodilution
controlled prospective evaluation. Presented in the ESC meeting. European Heart Journal
22;2001 Abstract Supplement:323 (page 1733)
64. Cotter G, Kaluski E, Milovanov O, Salah A, Krakover R, et al. LINCS: L-NMMA in
cardiogenic shock: preliminary results from a prospective randomized trial. Presented in
the ESC meeting. European Heart Journal 22;2001 Abstract Supplement:67 (page 463).
65. Blatt A, Robinson D, Nevo Z, Efrati S, Simantov Y, Sidenko S, Kaluski E et al. Improved
regional left ventricular function after successful satellite cell grafting in rabbits with
myocardial infarction. Presented in the ESC meeting. European Heart Journal 22;
2001 Abstract Supplement:490 (page 2669).
66. Blatt A, Robinson D, Nevo Z, Cotter G, Kaluski E, Vered Z. Successful satellite cells
grafting following myocardial infarction in rabbits. Presented in ACC 2001 meeting.
Circulation /Journal of American College of Cardiology 37-2 ACC 2001 Abstract
Supplement A 2001:1A-648A (Abstract 837-6).
67. Kaluski E, Tzimlichman R, Marmur A, Krakov O, Milovanov O, Caspi A, Vered Z,
Cotter G. RITZ 5: Randomized intravenous Tezosentan (an endothelin ET-A/B antagonist)
in the treatment of pulmonary edema: A prospective multi-center double-blind, placebo-
controlled study. Presented (oral presentation) at the 2002 ACC meeting (Atlanta)
Circulation /Journal of American College of Cardiology 39-5 2002: ACC 2002 Abstract
Supplement A (Abstract #1134-154).
68. Cotter G, Kaluski E, Milovanov O, Blatt A, Salah A, Hendler A, Krakover R, Vered Z.
LINCS: L-NMMA in cardiogenic shock: preliminary results from a prospective
randomized trial. Presented at the 2002 ACC meeting (Atlanta) Circulation /Journal of
American College of Cardiology 39-5 ACC 2002 Abstract Supplement A 2002: (Abstract
#862-5).
69. Cotter G, Tzoglin A, , Kaluski E, Moshkovitz Y, Salah A, Milovanov O, Krakover R,
Vered Z, Goor DA. Reliability of noninvasive cardiac output measurement by whole
body electrical bio-impedance in patients treated for acute congestive heart failure:
Presented (oral presentation at the 2002 ACC meeting (Atlanta) Circulation /Journal of
American College of Cardiology 39-5 ACC 2002 Abstract Supplement A 2002: (Abstract
#1014-152).
70. Cotter G, Tzoglin A, Moshkovitz Y, Kaluski E, Vered Z, Goor DA. Reliability of
noninvasive cardiac output measurement by whole body electrical bio-impedance:
comparison to thermodilution in diverse clinical settings. Presented at the 2002 ACC
meeting (Atlanta) Circulation /Journal of American College of Cardiology 39-5 ACC
2002 Abstract Supplement A 2002: (Abstract #1014-151).
71. Cotter G, Kaluski E, Milovanov O, Salah A, Krakover R, Vered Z. LINCS: L-NMMA in
cardiogenic shock: preliminary results from a prospective randomized study. Presented in
Heart Failure Update Meeting 2002. Published in European Journal of Heart Failure.
Cotter G, Kaluski E, Milovanov O, Salah A, Krakover R, Vered Z. Non invasive
calculation of cardiac power and vascular resistance for improved diagnosis of heart
failure and myocardial ischemia during dobutamine stress echocardiography stress test.
Cotter G, Tsoglin A, Kaluski E, Moshkovits Y, Milovanov O, Vered Z. Presented in
Heart Failure Update Meeting 2002. Published in European Journal of Heart Failure.
73. Shemesh E, Dinur I, Rudnick A, , Gilboa Shechtman E, Salah A, Milovanov O, Kaluski
24>
Share with your friends: |